Stay updated on Immunotherapy Combination Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combination Clinical Trial page.

Latest updates to the Immunotherapy Combination Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new version of a clinical study on metastatic prostate cancer, including the addition of a new drug, Epacadostat, and a change in the study's revision number from v2.14.4 to v2.15.0. Additionally, the previous background information on immunotherapy has been removed.SummaryDifference59%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
Stay in the know with updates to Immunotherapy Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combination Clinical Trial page.